{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:10:25Z","timestamp":1792793425137,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ajo.2022.12.021","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T02:58:40Z","timestamp":1673578720000},"page":"177-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Robotic CyberKnife Radiosurgery for the Treatment of Choroidal and Ciliary Body Melanoma"],"prefix":"10.1016","volume":"250","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6352-6259","authenticated-orcid":false,"given":"Raffael","family":"Liegl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Schmelter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Fuerweger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6177-1755","authenticated-orcid":false,"given":"Felix","family":"Ehret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegfried","family":"Priglinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Muacevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Foerster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ajo.2022.12.021_bib0001","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0161-6420(02)01277-0","article-title":"The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19","volume":"109","author":"Jampol","year":"2002","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2022.12.021_bib0003","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ophtha.2008.10.013","article-title":"I-125 brachytherapy for choroidal melanoma photographic and angiographic abnormalities: the Collaborative Ocular Melanoma Study: COMS report no. 30","volume":"116","author":"Boldt","year":"2009","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2022.12.021_bib0004","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.124.12.1684","article-title":"The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report no. 28","volume":"124","year":"2006","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2022.12.021_bib0005","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1136\/bjophthalmol-2015-306666","article-title":"Ruthenium-106 plaque brachytherapy for uveal melanoma","volume":"99","author":"Tarmann","year":"2015","journal-title":"Br J Ophthalmol"},{"issue":"970","key":"10.1016\/j.ajo.2022.12.021_bib0006","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1259\/bjr\/76813976","article-title":"Dosimetric comparison of 106Ru and 125I plaques for treatment of shallow (< or =5 mm) choroidal melanoma lesions","volume":"81","author":"Wilkinson","year":"2008","journal-title":"Br J Radiol"},{"issue":"2","key":"10.1016\/j.ajo.2022.12.021_bib0007","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/0284186X.2020.1820572","article-title":"Hypofractionated stereotactic photon radiotherapy of choroidal melanoma: 20-year experience","volume":"60","author":"Eibenberger","year":"2021","journal-title":"Acta Oncol"},{"issue":"6","key":"10.1016\/j.ajo.2022.12.021_bib0008","doi-asserted-by":"crossref","first-page":"965","DOI":"10.4149\/neo_2018_171209N808","article-title":"Uveal melanoma survival rates after single dose stereotactic radiosurgery","volume":"65","author":"Furdova","year":"2018","journal-title":"Neoplasma"},{"issue":"7","key":"10.1016\/j.ajo.2022.12.021_bib0009","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0161-6420(00)00150-0","article-title":"Stereotactic radiosurgery of large uveal melanomas with the gamma-knife","volume":"107","author":"Mueller","year":"2000","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2022.12.021_bib0010","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/CMR.0000000000000364","article-title":"Clinical experience of stereotactic radiosurgery at a linear accelerator for intraocular melanoma","volume":"27","author":"Furdova","year":"2017","journal-title":"Melanoma Res"},{"issue":"1","key":"10.1016\/j.ajo.2022.12.021_bib0011","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/CMR.0000000000000199","article-title":"Robotic radiosurgery for the treatment of medium and large uveal melanoma","volume":"26","author":"Eibl-Lindner","year":"2016","journal-title":"Melanoma Res"},{"issue":"1","key":"10.1016\/j.ajo.2022.12.021_bib0012","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijrobp.2009.07.1688","article-title":"Proton beam radiotherapy for uveal melanomas at nice teaching hospital: 16 years' experience","volume":"78","author":"Caujolle","year":"2010","journal-title":"Int J Radiat Oncol Biol Physics"},{"issue":"1","key":"10.1016\/j.ajo.2022.12.021_bib0013","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijrobp.2017.02.017","article-title":"Stereotactic radiosurgery and fractionated stereotactic radiation therapy for the treatment of uveal melanoma","volume":"98","author":"Yazici","year":"2017","journal-title":"Int J Radiat Oncol Biol Physics"},{"issue":"2","key":"10.1016\/j.ajo.2022.12.021_bib0014","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000501971","article-title":"Gamma Knife radiosurgery for uveal melanoma: a retrospective review of clinical complications in a tertiary referral center","volume":"6","author":"Modorati","year":"2020","journal-title":"Ocular Oncol Pathol"},{"issue":"1","key":"10.1016\/j.ajo.2022.12.021_bib0015","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/neuros\/nyx115","article-title":"Stereotactic radiosurgery and hypofractionated radiotherapy for glioblastoma","volume":"82","author":"Shah","year":"2018","journal-title":"Neurosurgery"},{"issue":"11","key":"10.1016\/j.ajo.2022.12.021_bib0016","doi-asserted-by":"crossref","first-page":"12318","DOI":"10.18632\/oncotarget.7131","article-title":"Stereotactic radiosurgery (SRS) in the modern management of patients with brain metastases","volume":"7","author":"Soliman","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ajo.2022.12.021_bib0017","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11060-009-9811-x","article-title":"Initial results of fractionated CyberKnife radiosurgery for uveal melanoma","volume":"94","author":"Zorlu","year":"2009","journal-title":"J Neuro-oncol"},{"issue":"8","key":"10.1016\/j.ajo.2022.12.021_bib0018","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/archophthalmol.2009.151","article-title":"Choroidal nevus transformation into melanoma: analysis of 2514 consecutive cases","volume":"127","author":"Shields","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2022.12.021_bib0019","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1097\/IAE.0000000000002440","article-title":"Choroidal nevus imaging features in 3,806 cases and risk factors for transformation into melanoma in 2,355 cases: the 2020 Taylor R. Smith and Victor T. Curtin Lecture","volume":"39","author":"Shields","year":"2019","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.ajo.2022.12.021_bib0020","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/153303460800700503","article-title":"Development of a streamlined, non-invasive robotic radiosurgery method for treatment of uveal melanoma","volume":"7","author":"Muacevic","year":"2008","journal-title":"Technol Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.ajo.2022.12.021_bib0021","doi-asserted-by":"crossref","first-page":"358","DOI":"10.5114\/jcb.2021.106191","article-title":"Efficacy and complications of ruthenium-106 brachytherapy for uveal melanoma: a systematic review and meta-analysis","volume":"13","author":"Karimi","year":"2021","journal-title":"J Contemp Brachytherapy"},{"issue":"6","key":"10.1016\/j.ajo.2022.12.021_bib0022","doi-asserted-by":"crossref","first-page":"548","DOI":"10.5114\/jcb.2017.72606","article-title":"Ruthenium brachytherapy for uveal melanoma\u2013single institution experience","volume":"9","author":"Rospond-Kubiak","year":"2017","journal-title":"J Contemp Brachytherapy"},{"issue":"10","key":"10.1016\/j.ajo.2022.12.021_bib0023","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00066-007-1734-x","article-title":"Impact of dose rate on clinical course in uveal melanoma after brachytherapy with ruthenium-106","volume":"183","author":"Mossb\u00f6ck","year":"2007","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"10.1016\/j.ajo.2022.12.021_bib0024","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5114\/jcb.2016.57818","article-title":"Ruthenium-106 brachytherapy for thick uveal melanoma: reappraisal of apex and base dose radiation and dose rate","volume":"8","author":"Naseripour","year":"2016","journal-title":"J Contemp Brachytherapy"},{"issue":"11","key":"10.1016\/j.ajo.2022.12.021_bib0025","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0161-6420(03)00661-4","article-title":"Iodine brachytherapy as an alternative to enucleation for large uveal melanomas","volume":"110","author":"Puusaari","year":"2003","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2022.12.021_bib0026","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00417-012-2144-z","article-title":"Gamma-knife-based stereotactic radiosurgery for medium- and large-sized posterior uveal melanoma","volume":"251","author":"Sarici","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2022.12.021_bib0027","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1034\/j.1600-0420.2003.00101.x","article-title":"Metastasis-free survival following treatment for uveal melanoma with either stereotactic radiosurgery or enucleation","volume":"81","author":"Cohen","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"issue":"5","key":"10.1016\/j.ajo.2022.12.021_bib0028","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.ijrobp.2005.01.016","article-title":"Proton beam radiotherapy of choroidal melanoma: the Liverpool-Clatterbridge experience","volume":"62","author":"Damato","year":"2005","journal-title":"Int J Radiat Oncol Biol Physics"},{"issue":"1","key":"10.1016\/j.ajo.2022.12.021_bib0029","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijrobp.2010.04.035","article-title":"Local tumor control, visual acuity, and survival after hypofractionated stereotactic photon radiotherapy of choroidal melanoma in 212 patients treated between 1997 and 2007","volume":"81","author":"Dunavoelgyi","year":"2011","journal-title":"Int J Radiat Oncol Biol Physics"},{"issue":"1","key":"10.1016\/j.ajo.2022.12.021_bib0030","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/bjo.2008.142208","article-title":"Gamma knife radiosurgery for uveal melanoma: 12 years of experience","volume":"93","author":"Modorati","year":"2009","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2022.12.021_bib0031","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1001\/archopht.120.12.1665","article-title":"Evidence-based estimates of outcome in patients irradiated for intraocular melanoma","volume":"120","author":"Gragoudas","year":"2002","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2022.12.021_bib0032","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0360-3016(01)01560-7","article-title":"Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma","volume":"51","author":"Egger","year":"2001","journal-title":"Int J Radiat Oncol Biol Physics"},{"issue":"9","key":"10.1016\/j.ajo.2022.12.021_bib0033","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/eye.2015.109","article-title":"Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma","volume":"29","author":"Sikuade","year":"2015","journal-title":"Eye (Lond)"},{"issue":"2","key":"10.1016\/j.ajo.2022.12.021_bib0034","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/bjo.78.2.109","article-title":"Impact of enucleation versus plaque radiotherapy in the management of juxtapapillary choroidal melanoma on patient survival","volume":"78","author":"De Potter","year":"1994","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2022.12.021_bib0035","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0161-6420(89)32882-X","article-title":"Recurrence of posterior uveal melanoma after 60Co episcleral plaque therapy","volume":"96","author":"Karlsson","year":"1989","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2022.12.021_bib0036","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal melanoma: trends in incidence, treatment, and survival","volume":"118","author":"Singh","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2022.12.021_bib0037","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ajo.2016.02.027","article-title":"Outcomes after proton beam therapy for large choroidal melanomas in 492 patients","volume":"165","author":"Bensoussan","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"24","key":"10.1016\/j.ajo.2022.12.021_bib0038","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-10-2076","article-title":"Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification","volume":"16","author":"Damato","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.ajo.2022.12.021_bib0039","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.ophtha.2013.03.012","article-title":"American Joint Committee on Cancer classification of posterior uveal melanoma (tumor size category) predicts prognosis in 7731 patients","volume":"120","author":"Shields","year":"2013","journal-title":"Ophthalmology"},{"issue":"22","key":"10.1016\/j.ajo.2022.12.021_bib0040","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.2012.45.2771","article-title":"Staging of ciliary body and choroidal melanomas based on anatomic extent","volume":"31","author":"Kujala","year":"2013","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ajo.2022.12.021_bib0041","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/bjo.2010.195594","article-title":"Proton beam therapy for the treatment of uveal melanoma in Scotland","volume":"95","author":"Macdonald","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2022.12.021_bib0042","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00417-021-05472-x","article-title":"Comparison of iodine-125 plaque brachytherapy and Gamma Knife stereotactic radiosurgery treatment outcomes for uveal melanoma patients","volume":"260","author":"Guleser","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2022.12.021_bib0043","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/jamaophthalmol.2017.3805","article-title":"Long-term outcomes after proton beam irradiation in patients with large choroidal melanomas","volume":"135","author":"Papakostas","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2022.12.021_bib0044","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijrobp.2013.05.051","article-title":"Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters","volume":"87","author":"Mishra","year":"2013","journal-title":"Int J Radiat Oncol Biol Physics"},{"issue":"11","key":"10.1016\/j.ajo.2022.12.021_bib0045","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s00417-017-3737-3","article-title":"Neovascular glaucoma after proton beam therapy of choroidal melanoma: incidence and risk factors","volume":"255","author":"Riechardt","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939422005190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939422005190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:54:18Z","timestamp":1757598858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939422005190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":44,"alternative-id":["S0002939422005190"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2022.12.021","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Robotic CyberKnife Radiosurgery for the Treatment of Choroidal and Ciliary Body Melanoma","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2022.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}